Diagnóstico por Imagem
Tecnologias inovadoras, como IA e robótica, estão no centro da imagiologia inteligente e são fulcrais para expandir a medicina de precisão, transformar a prestação de cuidados e melhorar a experiência do paciente. Com soluções de radiologia e medicina nuclear, que têm a transformação digital como foco na viagem do paciente, tem o futuro ao seu alcance. Explore alguns dos principais desenvolvimentos que vão construir o futuro dos cuidados de saúde.
Scroll through to see how our Diagnostic Imaging solutions support the COVID-19 diagnosis and monitoring.
Supporting radiologists in COVID-19 evaluation by applying Artificial Intelligence to images
Magnetic Resonance (MR) images used to support physicians in detecting cardiac injury in patients
Cardiac MRI can be useful to aid physicians detect and monitor cardiac injury (e.g. myocarditis).
X-ray systems support initial assessment of severity and monitoring
MOBILETT Elara Max
Diagnosis of COVID-19 and the role of Computed Tomography
CT images can help physicians differentiate between various types of infectious acquired diseases. In addition, our mobile CT workflow provides the capability for technologists to maintain a 1.5m (6 ft) distance from potentially infected patients.
Remote scanning assistance to ensure care continuity
Molecular imaging hybrid devices support screening demands
Hybrid molecular imaging devices can be used as stand alone Computed Tomography (CT) systems to perform a full range of CT applications, including high-resolution lung imaging protocols. Hybrid imaging systems can thereby extend CT capacity during peak demand.
High resolution Computed Tomography
High-resolution Biograph™ PET/CT and Symbia™ SPECT/CT systems can be used as stand alone CTs to aid in characterizing of lung changes.16
Supporting staff and preserving critical time with teamplay digital health platform
Easily share medical images in a secured environment to improve diagnostic certainty with teamplay Images
This offering is currently being provided automatically free of charge for 90 days.
teamplay myCare Companion remote care management
Specifically while during times of COVID-19, home monitoring of quarantined patients can be an opportunity for health providers to avoid the hospitalization of patients who are infected but not in a critical state. This frees up valuable resources for those patients who suffer from a severe course of disease.
We are fully committed to supporting our partners in the healthcare system to provide the best possible care for their patients.
Find out more information including disinfection recommendations for imaging scanners by clicking below.
The future of imaging
What do you think the future of imaging will look like? We believe emerging trends and shifting market dynamics are likely to have a major impact on imaging departments worldwide in the years to come. Using digital technologies to turn large amounts of data into insights, for instance, will support more precise diagnosis, targeted treatment, informed decision making and integrated diagnostics. Ultimately, intelligent imaging and digital transformation will lead to greater patient satisfaction. Watch the video to get more insights about what we think is to come in the years ahead.
Take a step into the future of imaging with our new highlights below.
SOMATOM X.cite with myExam Companion
SOMATOM On.site – Bringing critical care imaging to your patient
syngo Virtual Cockpit
MR Fingerprinting (MRF)
Artificial intelligence (AI) and machine learning are crucial today. The technology is making its way into routine clinical imaging as we speak, and radiology for all of us will be changed forever as a result.
See below how our solutions can enable you to respond to the growing demand for your diagnostic imaging services, address potential staff shortages, and enhance your overall imaging workflow.
Medicalis Referral Management and Medicalis Clinical Decision Support
FAST Integrated Workflow with FAST 3D Camera
BioMatrix Select&GO - intelligent body model in MRI
MR Dot Engines
MR Dot Engines – AutoAlign
Correction of MR motion artifacts
MR Dot Engine - AutoLabeling
Image based input function for Multiparametric PET
MM Reading in syngo.via
syngo.Breast Care VB 40
Prototype functionality: Lung Ventilation and Perfusion Analysis
AI-Rad Companion Chest CT
News & Stories about radiology and nuclear medicine
Products & Services
1The products/features (here mentioned) are not commercially available in all countries. Due to regulatory reasons their future availability cannot be guaranteed. Please contact your local Siemens Healthineers organization for further details.
2This product/feature is based on research. It is not yet commercially available. Due to regulatory reasons its future availability cannot be guaranteed.
3Not for clinical use.
4syngo.via can be used as a standalone device or together with a variety of syngo.via-based software options, which are medical devices in their own right. syngo.via and the syngo.via based software options are not commercially available in all countries. Due to regulatory reasons its future availability cannot be guaranteed. Please contact your local Siemens Healthineers organization for further details.
5Powered by TransparaTM, ScreenPoint Medical. syngo.Breast Care VB 40 are currently under development; are not for sale in the U.S. Their future availability cannot be guaranteed. Not all options are commercially available in all countries. Due to regulatory reasons its future availability cannot be guaranteed.
6Courtesy of Klinikum Nürnberg, Nuremberg, Germany,
AI-Rad Companion Engine has received 510k clearance. The Pulmonary and Cardiovascular extensions are 510(k) pending, and not yet commercially available in the United States. The musculoskeletal extension is work in progress, not commercially available, and its future availability cannot be ensured. Not for distribution or use in the U.S. The products/features (here mentioned) are not commercially available in all countries. Please contact your local Siemens Healthineers organization for further details.
7SOMATOM On.site is under development and not commercially available. Its future availability cannot be ensured.
8syngo Virtual Cockpit isn't commercially available in all countries. For regulatory reasons, its future availability can't be guaranteed. Precondition: Expert-i enabled modality from Siemens Healthineers.
9Magnetic Resonance Fingerprinting is currently under development and not commercially available. It is not for sale in the US or other countries. Its future availability cannot be guaranteed.
10The option is pending 510(k) clearance, and is not yet commercially available in the United States. Its future availability cannot be guaranteed.
11The products/features (mentioned herein) are not commercially available in all countries. Their future availability cannot be guaranteed.
12teamplay products are not commercially available in all countries. Due to regulatory reasons their future availability cannot be guaranteed.
Please contact your local Siemens Healthineers organization for further details.
13For Research Use Only. Not for use in diagnostic procedures.
14AI-Rad Companion Chest X-ray is currently not for sales in the United States and other selected countries.
15A secure VPN connection to the department network is required. Other appropriately trained personnel must be in the room to care for patient, position the patient, and manually start the scan.
16Note: Symbia T and Intevo Excel are not indicated for use as a Standalone CT
17Due to regulations data exchange between data center regions is restricted. The products/features/service offerings are not commercially available in all countries. If the services are not marketed in countries due to regulatory or other reasons, the service offering cannot be guaranteed. Please contact your local Siemens organization for further details.
18Shi S, Qin M, Shen B, et al. Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China. JAMA Cardiol. Published online March 25, 2020. doi:10.1001/jamacardio.2020.0950
19Guo T, Fan Y, Chen M, et al. Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. Published online March 27, 2020. doi:10.1001/jamacardio.2020.1017
20Inciardi RM, Lupi L, Zaccone G, et al. Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. Published online March 27, 2020. doi:10.1001/jamacardio.2020.1096